By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    benefits of using protein powder to build muscles
    Protein Powder for Muscle Mass: Everything You Need to Know
    December 12, 2021
    changes brought on by blockchain in healthcare
    Technology In The Healthcare Industry
    March 28, 2022
    What Does Core Body Temperature Say About Health?
    August 17, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    FDA Approves Diabetes Pill
    May 2, 2011
    Patient Gets Drunk on Hand Sanitizer
    June 20, 2011
    Cultivating Health Improvement
    July 20, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Right Result, Wrong Reason: VA Boots Avastin For Wet AMD
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Right Result, Wrong Reason: VA Boots Avastin For Wet AMD
Business

Right Result, Wrong Reason: VA Boots Avastin For Wet AMD

DavidEWilliams
Last updated: September 28, 2011 6:28 am
DavidEWilliams
Share
3 Min Read
SHARE

I’m a big fan of cost containment in health care. But I’m dead set against using a $50 shot of Avastin in place of a $2000 shot of Lucentis even if safety and efficacy are the same. Why? Because it has a chilling effect on innovation.

I’m a big fan of cost containment in health care. But I’m dead set against using a $50 shot of Avastin in place of a $2000 shot of Lucentis even if safety and efficacy are the same. Why? Because it has a chilling effect on innovation.

To make a long story short, Avastin is a highly-effective anti-cancer drug. Lucentis is basically the same drug, but it’s indicated for an ophthalmic condition: wet age-related macular degeneration. Since Lucentis is injected in the eye only a little bit is needed. Some enterprising doctors and pharmacists figured out they could split up one Avastin dose into lots of Lucentis doses. Instead of $2000 or so for a Lucentis treatment they have an Avastin equivalent for about $50.

In the short run only Genentech –maker of both Avastin and Lucentis– loses out. Patients get a much less expensive drug and insurance premiums are a little lower than they would be otherwise. But it’s also shown the world that the price point for a wet AMD treatment is $50 or so. As a result, drugmakers are reluctant to develop products in this therapeutic area because they are afraid they can’t make money.

More Read

5 Things CIOs Should Do in Light of the Recent Patient Records Theft
There’s No Business Like the Healthcare Business
Interview with Paul Tunnah Founder of Pharmaphorum
Hospice Fraud on the Rise
Anti-Trust Waiver for ACOs

The problem is really the way that drugs are priced. Avastin is priced by volume, but really what patients are getting is a treatment for cancer that’s worth a certain amount of money, regardless of the amount of physical product used.

Now safety concerns are emerging over the use of Avastin in the eye. These could easily be the result of problems with the compounding pharmacies. Nonetheless, the Veterans Administration for one has decided to stop substituting Avastin for Lucentis. As soon as that was announced, the stock price for Regeneron –maker of a Eylea, a new drug for wet AMD– jumped 9 percent, which supports my point about the impact on innovation. You can bet the VA action also increased the likelihood that companies with wet AMD drugs at earlier stages of development will take them forward. I hope some of those drugs make it to market, offering new and better options for patients at a price somewhere above Avastin but below Lucentis.


TAGGED:AvastinLucentispharmaceuticalsWet AMD
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Dental health
May 21, 2025
The Secret To A Confident Smile: Top Tips For Better Teeth
The Secret To A Confident Smile: Top Tips For Better Teeth
Dental health
May 21, 2025
Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025

You Might also Like

healthcare delivery
BusinessHealth ReformMedical EducationPolicy & Law

Changing the Way We Think

September 4, 2013

In the Battle of Doctor’s Orders Versus Patient Power, the Patient is Winning

March 5, 2012
BusinessDiagnosticseHealthMedical InnovationsTechnology

The Potential and Challenges for Internet of Things in Healthcare

February 2, 2018

Crowd-Sourcing in Clinical Development

July 25, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?